plc, of Dublin, Ireland, appointed Colin W. Stewart president, CEO and a member of the company's board, effective Aug. 16...Selecta Biosciences Inc., of Watertown, Mass., appointed Werner Cautreels president and CEO...Cautreels most recently served as CEO and global head of R&D at Solvay Pharmaceuticals Inc., acquired earlier this year by Abbott, of Abbott Park, Ill. (See BioWorld Today, Sept. 29, 2009

The firm also appointed Ronald Evans and David Mangelsdorf to its scientific advisory board

plc, of Dublin, Ireland, named Eliseo Oreste Salinas executive vice president and chief medical officer...Ikaria Inc., of Clinton, N.J., appointed Martin Meglasson chief science officer, and named Craig Tooman senior vice president and chief financial officer...Hueneme, Calif., appointed Malcolm Gefter to its board and scientific advisory board

The Foundation for the National Institutes of Health appointed Scott Campbell director and CEO...Taris Biomedical Inc., of Lexington, Mass., appointed Sarma Duddu president, CEO and a member of its board...Most recently, Duddu was general manager and vice president of worldwide drug delivery technologies at CIMA Labs Inc, a wholly owned subsidiary of Cephalon Inc., of Frazer, Pa

Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Bioheart Inc., of Sunrise, Fla., appointed Mike Tomas president, CEO and board member, replacing Karl Groth, who will retain his position as chairman...Jennerex Inc., of San Francisco, appointed Gregory W. Schafer senior vice president and chief financial officer

Novavax Inc., of Rockville, Md., appointed John W. Madsen head of process and manufacturing operations and named Steven Pincus head of analytical and quality operations...Probiodrug AG, of Halle, Germany, appointed Claus Braestrup chairman and named Lennart Mucke to its scientific advisory board

CombiMatrix Corp., of Mukilteo, Wash., named Mark McGowan interim president and CEO, effective July 1...Cyntellect Inc., of San Diego, appointed Saiid Zarrabian president and CEO...and Jonathan M. Spergel to its scientific advisory board

AMAG Pharmaceuticals Inc., of Lexington, Mass., named Gary J. Zieziula executive vice president and chief commercial officer...Synexus, of Manchester, UK, appointed Helena Sigal country manager for Germany and Radoslaw Janiak country manager for Poland...Vivus Inc., of Mountain View, Calif., named Michael P. Miller senior vice president and chief commercial officer

Algeta ASA, of Oslo, Norway, elected Judith Hemberger and Kapil Dhingra to its board of directors...Amgen Inc., of Thousand Oaks,Calif., appointed Robert A. Bradway president and chief operating officer...CMDBioscience, of Orange, Conn., appointed Erick Suchanek and Bernhardt Trout to its scientific advisory board

Allegro Diagnostics, of Boston, appointed Duncan Whitney vice president of research and development...Qiagen NV, of Venlo, the Netherlands, appointed Pia Garguilo and Richard Watts to its pharma business development team...Renhuang Pharmaceuticals Inc., of Harbin, China, appointed Changxiong Sun and Bingchun Wu to its board of directors as independent directors

He formerly was vice president of regulatory affairs and clinical research at Mystic Pharmaceuticals Inc...and served as senior consultant at Parexel International Corp...The company also named Sam Backenroth interim chief financial officer and vice president of business development

Semprus BioSciences Inc, of Cambridge, Mass., appointed Colin R. Gardner and Michael J. Cima to its scientific advisory board...Spectral Diagnostics Inc., of Toronto, appointed Kevin Giese and Laine Woollard to its board...TrovaGene Inc., of San Diego, named Andreas Braun vice president and chief medical officer

Afraxis, of San Diego, appointed David Campbell chief scientific officer and named Carmine Stengone vice president of corporate development...EUSA Pharma, of Oxford, UK, named Iain McGill president, Europe and International...GeoVax Labs Inc., of Smyrna, Ga., added Steven Antebi and David A. Dodd to its board

De Souza was previously president and CEO of Synaptic Pharmaceuticals, president and CEO of Archemix Corp., co-founder and chief scientific officer of Neurocrine Biosciences, senior vice president at Aventis and director of CNS diseases research at DuPont Merck

No CEO replacement was named, but the firm said Mel Bridges and John Chiplin both will move to executive director roles within the company...Karo Bio AB, of Stockholm, Sweden, appointed Fredrik Lindgren as CEO and president, succeeding Per Olof Wallström, who has resigned and is leaving the company

AspenBio Pharma Inc., of Castle Rock, Colo., has appointed Steve Lundy CEO and a member of its board...IGEN Networks Corp., of Las Vegas, appointed Monty Ormsby president and Michael Grudman chief financial officer and secretary

CEO Appointments: Action Pharma, of Holte, Denmark, has appointed Ingelise Saunders as CEO...Before joining Action she was president and CEO of ACE BioSciences for five years, and prior to that was CEO of Celltech Pharmaceuticals Plc...as vice president of worldwide licensing and external research and vice president of basic research

Tekmira Pharmaceuticals Corp., of Vancouver, British Columbia, appointed Daniel Kisner chairman and named Kenneth Galbraith and Frank Karbe to its board...Trevena Inc., of King of Prussia, Pa., named David Soergel vice president and head of clinical development

to vice president of financing and administration...Pepscan Therapeutics, of Lelystad, the Netherlands, named Peter Timmerman chief technology officer and appointed Klaus Schwamborn chief development officer